Jinhe's main business consists of three parts:
1、Raw materials of anticancer drugs:
Jinhe, provides high-quality Paclitaxel Natural USP29, Paclitaxel (Semi-synthetic) USP31, Docetaxel Anhydrous (Trihydrate), Irinotecan HCl Trihydrate 99.5%, Palonosetron Hydrochloride, Etoposide USP31 and other products, in accordance with USP standard and other international standards.
2、Anti-cancer pharmaceutical intermediates.:
Jinhe, is able to provide high-purity intermediates for synthesis of Paclitaxel and Docetaxel, mainly including 10 DAB III, Baccatin III13-acetyl-9-dihydrobaccatin III (9-DHB) etc.
Jinhe, is able to provide many kinds of side-chains for synthetic of Palitaxel and docetaxel, mainly including (2R,3S)-3-Phenylisoserine Hydrochloride(2R,3S)-N- benzoyl-3-Phenylisoserine Methyl Ester (2R,3S)-N-tert-butoxycarbonyl-3-Phenylisoserine Methyl Ester etc.
Jinhe, is able to provide high-purity intermediates for synthesis of Etoposide USP31 (VP16), mainly including Podophyllotoxin and 4’-Demethyl-epi- Podophyllotoxin etc.
3、Processing business of Taxus biomass:
Jinhe is able to process Taxus biomass according to customer requirements
and in compliance with international standards, and help our clients in respect of the legitimate formality. The varieties include: Taxus cannadensis, Taxus baccata, Taxus media and T. chinensis var. mairer Cheng et L. K. Fu etc..
|
